MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
57.80
+1.88 (3.36%)
At close: Jul 2, 2026, 4:00 PM EDT
58.00
+0.20 (0.35%)
After-hours: Jul 2, 2026, 7:44 PM EDT
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $2.75 billion as of July 2, 2026. Its market cap has increased by 714.94% in one year.
Market Cap
2.75B
Enterprise Value
2.31B
1-Year Change
714.94%
Ranking
Category
Stock Price
$57.80
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has increased from $509.66M to $2.75B, an increase of 439.80%. That is a compound annual growth rate of 155.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 2.75B | 94.26% |
| Dec 31, 2025 | 1.42B | 129.95% |
| Dec 31, 2024 | 615.88M | 20.84% |
| Sep 13, 2024 | 509.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celldex Therapeutics | 3.01B |
| Vera Therapeutics | 2.96B |
| Disc Medicine | 2.91B |
| uniQure | 2.87B |
| Kailera Therapeutics | 2.85B |
| Tarsus Pharmaceuticals | 2.82B |
| SELLAS Life Sciences Group | 2.79B |
| Immunome | 2.67B |